Most Clicked StoriesMore >


EMA releases analysis on challenges of CNS drug development

DIA Global SmartBrief | Dec 01, 2016

Research on drugs for the central nervous system is more complex and has a higher failure rate during clinical development compared with treatments in other medical fields, according to an analysis published by the European Medicines Agency. More than a third of applications for CNS drugs had issues regarding clinical safety and efficacy in late-stage studies, and the agency advised that drugmakers be more careful in designing their early-stage studies to increase their chances of success. Regulatory Focus (11/29)


Guidance on drug labeling finalized by FDA

DIA Global SmartBrief | Dec 06, 2016

US FDA gives warning letter to Chinese heparin processor

DIA Global SmartBrief | Dec 06, 2016

GSK to study injectable PrEP therapy

DIA Global SmartBrief | Dec 01, 2016

Scripps researchers move opioid vaccines to human trials

DIA Global SmartBrief | Dec 01, 2016

Small, specialized drugmakers may gain in rare-disease market

DIA Global SmartBrief | Dec 06, 2016

GSK seeks EMA approval for shingles vaccine

DIA Global SmartBrief | Dec 01, 2016

Janssen's leukemia treatment gains NICE backing

DIA Global SmartBrief | Dec 06, 2016

HIV vaccine to move to midstage trials

DIA Global SmartBrief | Dec 06, 2016

Allergan, Amgen seek EU approval for Avastin biosimilar

DIA Global SmartBrief | Dec 06, 2016


Find DIA Global SmartBrief Issues by Date:



DIA News More >


DIA event spotlight!

DIA Global SmartBrief | Dec 08, 2016

Lowest possible rates for DIA 2017!

DIA Global SmartBrief | Dec 08, 2016

DIA upcoming event highlights

DIA Global SmartBrief | Dec 01, 2016

Become a DIA member

DIA Global SmartBrief | Dec 01, 2016

Explore the November Journal

DIA Global SmartBrief | Nov 17, 2016




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more